Acclarent Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
240
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$280M
Acclarent General Information
Description
Developer of medical devices intended to address conditions affecting the ear, nose, and throat. The company primarily focuses on commercializing balloon sinuplasty devices, which are minimally invasive tools that aid physicians in treating patients suffering from chronic sinusitis, enabling doctors to navigate the sinus anatomy and open blocked sinus ostia and passageways to allow for sinus drainage.
Contact Information
Website
www.acclarent.comCorporate Office
- 33 Technology Drive
- Irvine, CA 92618
- United States
Corporate Office
- 33 Technology Drive
- Irvine, CA 92618
- United States
Acclarent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Apr-2024 | $280M | Completed | Generating Revenue | ||
| 6. Merger/Acquisition | 20-Jan-2010 | Completed | Generating Revenue | |||
| 5. IPO | 06-Jun-2008 | Cancelled | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 31-Mar-2008 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 23-Apr-2007 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 27-Dec-2005 | $28M | $42.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jan-2003 | $14.5M | $14.5M | Completed | Generating Revenue |
Acclarent Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 13,357,773 | $0.17 | $2.1 | $2.1 | 1x | $2.1 | 22.7% | |
| Series A | 14,071,484 | $0.08 | $1.04 | $1.04 | 1x | $1.04 | 23.78% |
Acclarent Comparisons
Industry
Financing
Details
Acclarent Competitors (12)
One of Acclarent’s 12 competitors is Dalent, a Venture Capital-Backed company based in Miami, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dalent | Venture Capital-Backed | Miami, FL | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| DePuy Spine | Corporation | Raynham, MA | ||||
| Navigate Surgical Technologies | Venture Capital-Backed | Vancouver, Canada | ||||
| NEUROMARK | Venture Capital-Backed | Braintree, MA |
Acclarent Signals
Acclarent Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delphi Ventures (California) | Venture Capital | Minority | ||
| Ethicon | Corporation | Majority | ||
| ExploraMed | Accelerator/Incubator | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Meritech Capital Partners | Venture Capital | Minority |
Acclarent FAQs
-
When was Acclarent founded?
Acclarent was founded in 2003.
-
Where is Acclarent headquartered?
Acclarent is headquartered in Irvine, CA.
-
What is the size of Acclarent?
Acclarent has 240 total employees.
-
What industry is Acclarent in?
Acclarent’s primary industry is Surgical Devices.
-
Is Acclarent a private or public company?
Acclarent is a Private company.
-
What is the current valuation of Acclarent?
The current valuation of Acclarent is .
-
What is Acclarent’s current revenue?
The current revenue for Acclarent is .
-
How much funding has Acclarent raised over time?
Acclarent has raised $104M.
-
Who are Acclarent’s investors?
Delphi Ventures (California), Ethicon, ExploraMed, Johnson & Johnson JJDC, and Meritech Capital Partners are 5 of 7 investors who have invested in Acclarent.
-
Who are Acclarent’s competitors?
Dalent, Spine Wave, DePuy Spine, Navigate Surgical Technologies, and NEUROMARK are some of the 12 competitors of Acclarent.
-
When was Acclarent acquired?
Acclarent was acquired on 01-Apr-2024.
-
Who acquired Acclarent?
Acclarent was acquired by Integra LifeSciences Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process